scispace - formally typeset
Journal ArticleDOI

Classic Interstitial Cystitis: Unrelated to BPS

TLDR
Recent progress in the understanding of the BPS/IC complex will be discussed, emphasizing the fact that the classic Hunner disease (BPS type 3C according to the European Society for the Study of Interstitial Cystitis (ESSIC) classification) is a well-defined condition that fulfills the requirements of the denomination interstitial cystitis.
Abstract
When first recognized, more than one hundred years ago, the term interstitial cystitis (IC) was reserved for subjects with a special type of deep inflammation of the bladder wall. Later, the scope of IC widened, including all kinds of bladder pain syndromes (BPS), giving rise to a lot of confusion and difficulties in research as well as in clinical practice. Herein, recent progress in the understanding of the BPS/IC complex will be discussed, emphasizing the fact that the classic Hunner disease (BPS type 3C according to the European Society for the Study of Interstitial Cystitis (ESSIC) classification) is a well-defined condition that fulfills the requirements of the denomination interstitial cystitis. The paper will also discuss recent research on diagnostics, markers, genetics, and various types of remedies for classic IC. For the benefit of our patients, in BPS/IC, it is time for a final separation of the concepts BPS and IC. Classic IC is a well-defined entity with multiple unique characteristics, those characteristics having a potential for development of a specific rational, pharmacological, and surgical treatment algorithm if further investigated. BPS, on the other hand, seems to include a heterogenic composition of conditions calling for broad attempts to be more closely explored.

read more

Citations
More filters
Journal ArticleDOI

Interstitial Cystitis/Bladder Pain Syndrome.

TL;DR: The exact longitudinal course by which peripheral and central aberrations involving the bladder mucosa, peripheral inflammation, and central dysregulation of bladder sensitivity create painful bladder symptoms remains an area in need of further study as mentioned in this paper.
Journal ArticleDOI

Role of cystoscopy and hydrodistention in the diagnosis of interstitial cystitis/bladder pain syndrome.

TL;DR: The recommendations of various societies and associations of greater impact in this complex disease are reviewed, analyzing the indications, technique, findings and complications of this procedure.
Journal ArticleDOI

Women's Experiences of Interstitial Cystitis/Painful Bladder Syndrome.

TL;DR: In this article, a phenomenological approach with emphasis on reflection and openness was adopted to explore the lived experience of interstitial cystitis (IC)/painful bladder syndrome (PBS).
Journal ArticleDOI

A New Approach to Urologic Chronic Pelvic Pain Syndromes: Applying Oncologic Principles to “Benign” Conditions

TL;DR: The urologic chronic pelvic pain syndromes (UCPPS) continue to be both a major cause of morbidity in patients and huge challenge to clinicians as discussed by the authors, due to patients having common symptoms but differing underlying pain mechanisms.
References
More filters
Journal ArticleDOI

The interstitial cystitis symptom index and problem index

TL;DR: Both indices should be useful in the evaluation and management of patients with IC and should be particularly useful in clinical trials of new therapies for this condition, where reliable, validated, and reproducible outcome measures are critically important.
Journal ArticleDOI

Prevalence of Symptoms of Bladder Pain Syndrome/Interstitial Cystitis Among Adult Females in the United States

TL;DR: It is suggested that bladder pain syndrome/interstitial cystitis symptoms are widespread among United States women and associated with considerable disability, and underdiagnosed, and this first population based symptom prevalence estimate is provided.
Journal ArticleDOI

Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies.

TL;DR: An improved immunohistochemical technique for distinguishing human mast cells of the MCT and MCTC types utilizing a biotinylated murine anti-chymase monoclonal antibody (MAb), termed B7, and an alkaline phosphatase-conjugated murines anti-tryptase MAb, termed G3 is developed.
Related Papers (5)